IP Review

This publication includes IP covered under the following statements.

ISO maintains the copyright on the country codes, and controls its use carefully. For further details see the ISO 3166 web page: https://www.iso.org/iso-3166-country-codes.html
Show Usage
- ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code : Alerts2FHIRCzPs , Attachments2FHIRCzPs ... Show 77 more
This material contains content from LOINC . LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license . LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
Show Usage
- LOINC : Bundle/cz-example-bundle-ps , Bundle/cz-example-bundle-ps-L1 ... Show 8 more
This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Show Usage

hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide ®© HL7 | CC0 ( src )

Code of Federal Regulation 21CFR§1271.290(c) ( src )

HL7 Czech PS Implementation Guide, published by HL7 Czech Republic. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7-cz/ps/ and changes regularly. See the Directory of published versions ( src )

There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose. For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine® (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting". In these cases, two medication requests would be created that could be grouped together. The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. ( src )

This material contains content from LOINC. LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. Show Usage * LOINC: Bundle/cz-example-bundle-ps, Bundle/cz-example-bundle-ps-L1... Show 8 more , CZ_CompositionPs, CZ_ConsentPs, CZ_ImmunizationRecommendationPs, CZ_ObservationAlcoholUsePs, CZ_ObservationPregnancyStatusPs, CZ_ObservationTobaccoUsePs, Composition/a082a2ac-7cd0-4444-8819-73580dd1b120 and Observation/4eceb19d-d67b-4520-badf-9bbf20cd6046 ( src )

This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html Show Usage * Consent Scope Codes: Bundle/cz-example-bundle-ps, CZ_ConsentObligationsPs, CZ_ConsentPs and Consent/054899d6-4868-40cb-a9cc-a52f93e2d22f * identifierType: CZ_PatientObligationsPs * providerRole: CZ_ImmunizationObligationsPs and CZ_ImmunizationPs ( src )

External References

Unattributed Code Systems

Copyright Fragment

Copyright and Registered Trademark Uses

External References

Internal Images